Stockscreener 앱 받기
5.13
1.63%
-0.09
시간 외 거래:
5.13
전일 마감가:
$5.22
열려 있는:
$5.03
하루 거래량:
566.73K
Relative Volume:
0.76
시가총액:
$281.61M
수익:
$124.00K
순이익/손실:
$-49.99M
주가수익비율:
-3.0355
EPS:
-1.69
순현금흐름:
$-31.03M
1주 성능:
-8.30%
1개월 성능:
-7.64%
6개월 성능:
-2.75%
1년 성능:
-1.06%
1일 변동 폭
$5.03
$5.27
1주일 범위
$5.03
$5.80
52주 변동 폭
$3.785
$14.60
Candel Therapeutics Inc Stock (CADL) Company Profile
명칭
Candel Therapeutics Inc
전화
617-916-5445
주소
117 KENDRICK STREET, NEEDHAM
CADL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
5.13 | 286.55M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-06-30 | 재개 | H.C. Wainwright | Buy |
| 2025-02-20 | 개시 | Citigroup | Buy |
| 2025-02-19 | 개시 | Canaccord Genuity | Buy |
| 2025-02-07 | 개시 | BofA Securities | Buy |
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-08-23 | 개시 | Credit Suisse | Outperform |
| 2021-08-23 | 개시 | Jefferies | Buy |
| 2021-08-23 | 개시 | UBS | Buy |
모두보기
Candel Therapeutics Inc 주식(CADL)의 최신 뉴스
Candel Therapeutics to present phase 3 prostate cancer trial data at SITC - Investing.com
Candel Therapeutics to highlight immunotherapy advances at SITC 2025 - Proactive financial news
Candel Therapeutics Presents Innovative Immunotherapy Data at SITC 2025 Annual Meeting - Quiver Quantitative
Candel Therapeutics Showcases Immunotherapy Leadership at - GlobeNewswire
Can Candel Therapeutics Inc. stock weather global recessionWeekly Profit Analysis & Technical Pattern Recognition Alerts - newser.com
How Candel Therapeutics Inc. stock performs in stagflationQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Candel Therapeutics to present at Jefferies Global Healthcare Conference - Proactive financial news
Can volume confirm reversal in Candel Therapeutics Inc.CEO Change & Daily Entry Point Alerts - newser.com
What the charts say about Candel Therapeutics Inc. todayTrade Signal Summary & Capital Efficient Trading Techniques - newser.com
Will Candel Therapeutics Inc. stock reach all time highs in 20252025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London - The Manila Times
Candel Therapeutics, Inc. CEO Paul Peter Tak to Present at Jefferies Global Healthcare Conference 2025 - Quiver Quantitative
Will Candel Therapeutics Inc. see short term momentumJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
What technical models suggest about Candel Therapeutics Inc.’s comebackTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
Is Candel Therapeutics Inc. building a consolidation baseJuly 2025 Market Mood & Weekly Momentum Picks - newser.com
How geopolitical tensions affect Candel Therapeutics Inc. stock2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
How Candel Therapeutics Inc. stock compares to growth peersJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
Intraday pattern recognizer results for Candel Therapeutics Inc.2025 Risk Factors & Daily Chart Pattern Signals - newser.com
What’s next for Candel Therapeutics Inc. stock priceOil Prices & Detailed Earnings Play Strategies - newser.com
Can Candel Therapeutics Inc. stock sustain revenue growth2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Why analysts upgrade Candel Therapeutics Inc. stockJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Will Candel Therapeutics Inc. stock outperform international peersMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Candel Therapeutics Inc. stock benefit from automationLong Setup & Real-Time Stock Entry Alerts - newser.com
Candel Therapeutics Inc (CADL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):